Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01173653 · ClinicalTrials.gov registry record · NA

Smoking Cessation Invention in the Emergency Department (ED)

A NA study, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
199
Enrollment target

NCT01173653: Completed NA study, sponsored by Vanderbilt University.

NCT01173653 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 199 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01173653, a NA study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
199 participants
Enrollment target

Study Summary

The emergency department (ED) serves a vital and growing role in the US health care system, responsible for both the delivery of emergent medical care and for safety-net care for populations without traditional access to health services. Uninsured populations rely significantly on the safety-net services of the ED. Between 2000-2005 the number of uninsured Americans increased from 39.6 million to 46.1 million, and this growth is expected to continue. Many health policy analysts consider the ED to be an effective place to provide preventative care. Prophylactic tetanus immunization, for example, has been a successful preventive health intervention that has become a standard of care in the ED setting. Brief smoking cessation interventions have been introduced in the ED but have not had great success based on lack of follow-up and continuity. Our study is novel in that it introduces a brief smoking intervention through use of an established, federally-funded and federally-sponsored cessation counseling resource, the National Smoking Cessation Quit Line, also available at smokefree.gov. This is a joint initiative between the Tobacco Control Research Branch of the National Cancer Institute and the Centers for Disease Control and Prevention. Since ED patients who smoke often lack the ability to use self-help cessation resources, we hypothesize that by introducing this population to the counselors on the National Smoking Cessation Quit Line (also called the 1-800-QUIT-NOW line) during the ED visit via phone, that this new brief intervention would have a realizable and significant effect on smoking cessation among the this population.

Primary Outcome

Patients enrolled in this study were contacted via phone to assess smoking status. Smoking status was a self-report from each subject. Primary outcome measure is the smoking status of the enrollee at the time of follow-up contact. We calculated the percentage of participants who had stopped smoking at the 6 week follow-up period in each arm

Interventions

  • OTHER Smoking Cessation

Trial Details

FieldValue
Enrollment Target 199 participants
Start Date 2010-07
Est. Completion 2011-01
Phase NA
Vanderbilt University

430 total trials

What the finished NCT01173653 record still lists

NCT01173653 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Smoking Cessation is the first listed.

NCT01173653 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01173653 about?

NCT01173653 is a clinical study titled "Smoking Cessation Invention in the Emergency Department (ED)". The emergency department (ED) serves a vital and growing role in the US health care system, responsible for both the delivery of emergent medical care and for safety-net care for populations without traditional access to health services. Uninsured populations rely significantly on the safety-net ser...

What is the current status of trial NCT01173653?

This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2010-07. Estimated completion is 2011-01.

What interventions are being tested in trial NCT01173653?

The interventions under investigation include: Smoking Cessation (OTHER).

Who is sponsoring clinical trial NCT01173653?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01173653's enrollment target sits among peer trials

199 567th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04312126 · 199 participants

    The Beneficial Effects of Naps on Motor Learning

  • NCT04951622 · 199 participants · Phase 3

    A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  • NCT06474533 · 199 participants

    Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01173653, the US trial registry maintained by the National Library of Medicine. NCT01173653 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.